|
 |
| home > ebr > winter 2003 > streamlining phase i through a successful partnership strategy |
|
|
 PUBLICATIONS |
European BioPharmaceutical Review
|
| The industry is under increasing pressure to streamline all phases of new drug development and significant emphasis is being placed on the ability of Phase I to identify and 'kill' unsatisfactory candidates quickly and efficiently. At the same time, this phase must arm the winners with not just safety information, but as much efficacy data as possible to help smooth the transition into later-phase clinical trials. These trends have strategic implications not only in the design of studies and programmes, but also in the organisation of R&D and selection of outsourced development partners. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
EuroBiopartnering 2008
7-9 October 2008, Paris, France
EuroBiOpartnering
2008 gives you the unique opportunity to meet the relevant decision makers and
opinion leaders from the international biotech community and offers you 3 days
of partnering opportunities including one-to-one meetings, company presentations
and further networking activities…
More info >> |
|
 |
News and Press Releases |
 |
MipTec, October 14 – 16, 2008, Switzerland
MipTec about to take off by joining forces between Life Sciences Week, ALL-SystemsX.ch-Day, & Jobvector.com
More info >> |
|
|
